These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25541377)

  • 21. Microparticles and pregnancy complications.
    Aharon A; Brenner B
    Thromb Res; 2011 Feb; 127 Suppl 3():S67-71. PubMed ID: 21262446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preeclampsia as a maternal vascular disease].
    Amash A; Huleihel M; Sheiner E; Sapir O; Holcberg G
    Harefuah; 2007 Sep; 146(9):707-12, 733. PubMed ID: 17969310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-eclampsia: clinical manifestations and molecular mechanisms.
    Baumwell S; Karumanchi SA
    Nephron Clin Pract; 2007; 106(2):c72-81. PubMed ID: 17570933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Defective placental implantation and its effects on maternal endothelial function].
    Foidart JM; Noël A; Chantraine F; Lorquet S; Petit P; Munaut C; Berndt S; Pequeux C; Schaaps JP
    Bull Acad Natl Med; 2009 May; 193(5):1059-64; discussion 1064-6, 1067-8. PubMed ID: 20120387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial cells and peripheral blood mononuclear cells are a potential source of extraplacental activin a in preeclampsia.
    Tannetta DS; Muttukrishna S; Groome NP; Redman CW; Sargent IL
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5995-6001. PubMed ID: 14671202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial dysfunction in preeclampsia.
    Roberts JM
    Semin Reprod Endocrinol; 1998; 16(1):5-15. PubMed ID: 9654603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR.
    Cozzi V; Garlanda C; Nebuloni M; Maina V; Martinelli A; Calabrese S; Cetin I
    Placenta; 2012 Dec; 33(12):1039-44. PubMed ID: 23062219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trophoblast debris extruded from preeclamptic placentae activates endothelial cells: a mechanism by which the placenta communicates with the maternal endothelium.
    Shen F; Wei J; Snowise S; DeSousa J; Stone P; Viall C; Chen Q; Chamley L
    Placenta; 2014 Oct; 35(10):839-47. PubMed ID: 25096950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunohistochemical evaluation of the distribution of vascular endothelial growth factor in the placenta, placental bed in normal pregnancy and in women with preeclampsia].
    Milovanov AP; Sidorova IS; Solonitsyn AN; Borovkova EI
    Arkh Patol; 2008; 70(3):12-5. PubMed ID: 18727425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Placental trophoblast-derived factors diminish endothelial barrier function.
    Wang Y; Lewis DF; Gu Y; Zhang Y; Alexander JS; Granger DN
    J Clin Endocrinol Metab; 2004 May; 89(5):2421-8. PubMed ID: 15126573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypothesis: Pentoxifylline explores new horizons in treatment of preeclampsia.
    Azimi A; Ziaee SM; Farhadi P; Sagheb MM
    Med Hypotheses; 2015 Oct; 85(4):468-74. PubMed ID: 26164832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin improves endothelial function in vitro and prolongs pregnancy in women with early-onset preeclampsia.
    Hobson SR; Gurusinghe S; Lim R; Alers NO; Miller SL; Kingdom JC; Wallace EM
    J Pineal Res; 2018 Oct; 65(3):e12508. PubMed ID: 29766570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: evidence for a significant regulatory role in preeclampsia at placental and systemic levels.
    Kunjara S; Greenbaum AL; Wang DY; Caro HN; McLean P; Redman CW; Rademacher TW
    Mol Genet Metab; 2000 Feb; 69(2):144-58. PubMed ID: 10720442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of microparticles and preeclampsia.
    Marques FK; Campos FM; Sousa LP; Teixeira-Carvalho A; Dusse LM; Gomes KB
    Mol Biol Rep; 2013 Jul; 40(7):4553-9. PubMed ID: 23645085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathophysiology and clinical manifestations in pre-eclampsia].
    Haram K; Bjørge L; Guttu K
    Tidsskr Nor Laegeforen; 2000 May; 120(12):1426-31. PubMed ID: 10851940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preeclampsia: the role of angiogenic factors in its pathogenesis.
    Wang A; Rana S; Karumanchi SA
    Physiology (Bethesda); 2009 Jun; 24():147-58. PubMed ID: 19509125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of uric acid in preeclampsia-eclampsia].
    Vázquez-Rodríguez JG; Rico-Trejo EI
    Ginecol Obstet Mex; 2011 May; 79(5):292-7. PubMed ID: 21966818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia.
    Taylor RN; de Groot CJ; Cho YK; Lim KH
    Semin Reprod Endocrinol; 1998; 16(1):17-31. PubMed ID: 9654604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Ureaplasma urealyticum in altering the endothelial metal concentration during preeclampsia.
    Padmini E; Uthra V
    Placenta; 2012 Apr; 33(4):304-11. PubMed ID: 22280558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential biomarkers of preeclampsia: inverse correlation between hydrogen peroxide and nitric oxide early in maternal circulation and at term in placenta of women with preeclampsia.
    Aris A; Benali S; Ouellet A; Moutquin JM; Leblanc S
    Placenta; 2009 Apr; 30(4):342-7. PubMed ID: 19223072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.